Management discusses 3Q earnings results, abstracts to be presented at the upcoming ASH Annual Meeting and development plans for Sickle Cell Disease on a conference call to be held on November 2 at 8 am.
Webcast: http://investor.bluebirdbio.com/events-and-presentations/upcoming-events
https://thefly.com/landingPageNews.php?id=2815861
https://thefly.com/landingPageNews.php?id=2815861
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.